CompaniesCorvidia Therapeutics

Corvidia Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

32

By Phase

PHASE1: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
Today
NCT03126318
Hover over trial bars to see details

Recent Trials

NCT03126318Collaborator
A Study of Patients With Chronic Kidney Disease to Assess the Safety of a Single Dose of COR-001
PHASE1Completed
32 participants
Started: May 19, 2017 · Completed: Dec 19, 2019
Funding History (1)
D
May 1, 2018
Filing
Related Companies
Novo Nordisk
acquired